Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2Hyperandrogenism 1

Interventions

Spironolactone 2Progesterone 2salicylsalicylic acid 1maltodextrin 1drospirenone and ethinyl estradiol combination 1Sodium Salicylate 1Sex Characteristics 1Physical Examination 1Magnesium 1Inulin 1Inositol 1Carnitine 1Blood Pressure Monitoring, Ambulatory 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperandrogenism × drospirenone and ethinyl estradiol combination × 1 year × Clear all
NCT03819140 2025-11-14

CCOUP

University of California, San Francisco

Phase 4 Completed
51 enrolled 15 charts

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡